{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 33835, "items": [{"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T09:08:54Z", "timestamp": 1525770534740}, "reference-count": 0, "publisher": "VM Media SP. zo.o VM Group SK", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.5603/piap.2014.0013", "type": "journal-article", "created": {"date-parts": [[2014, 3, 11]], "date-time": "2014-03-11T13:20:08Z", "timestamp": 1394544008000}, "page": "79-81", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Systemowe leczenie chorych na niedrobnokom\u00f3rkowego raka p\u0142uca \u2014 od nihilizmu do nadziei"], "prefix": "10.5603", "volume": "82", "author": [{"given": "Jacek Jassem", "family": "Jacek Jassem", "sequence": "first", "affiliation": []}], "member": "3595", "published-online": {"date-parts": [[2014, 3, 4]]}, "container-title": ["Pneumonologia i Alergologia Polska"], "link": [{"URL": "https://journals.viamedica.pl/advances_in_respiratory_medicine/article/viewFile/37370/26553", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 12, 28]], "date-time": "2017-12-28T10:50:44Z", "timestamp": 1514458244000}, "score": 30.579514, "issued": {"date-parts": [[2014, 3, 4]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2014, 3, 4]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.5603/piap.2014.0013", "ISSN": ["2299-8292", "0867-7077"], "issn-type": [{"value": "0867-7077", "type": "print"}, {"value": "2299-8292", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T14:28:24Z", "timestamp": 1525357704604}, "reference-count": 14, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 1, 1]], "date-time": "2003-01-01T00:00:00Z", "timestamp": 1041379200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Current Problems in Cancer"], "published-print": {"date-parts": [[2003, 1]]}, "DOI": "10.1067/mcn.2003.12", "type": "journal-article", "created": {"date-parts": [[2003, 2, 5]], "date-time": "2003-02-05T05:48:50Z", "timestamp": 1044424130000}, "page": "69-73", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Modern management of symptoms and quality of life"], "prefix": "10.1067", "volume": "27", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}, {"given": "Ewa", "family": "Jassem", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Current Problems in Cancer"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0147027202000144?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0147027202000144?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 15]], "date-time": "2017-06-15T17:43:15Z", "timestamp": 1497548595000}, "score": 27.963768, "issued": {"date-parts": [[2003, 1]]}, "references-count": 14, "journal-issue": {"published-print": {"date-parts": [[2003, 1]]}, "issue": "1"}, "alternative-id": ["S0147027202000144"], "URL": "http://dx.doi.org/10.1067/mcn.2003.12", "ISSN": ["0147-0272"], "issn-type": [{"value": "0147-0272", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 4, 17]], "date-time": "2018-04-17T20:35:20Z", "timestamp": 1523997320692}, "reference-count": 0, "publisher": "BMJ", "issue": "1", "content-domain": {"domain": ["bmj.com"], "crossmark-restriction": true}, "short-container-title": ["ESMO Open"], "published-print": {"date-parts": [[2016, 2]]}, "DOI": "10.1136/esmoopen-2016-000043", "type": "journal-article", "created": {"date-parts": [[2016, 11, 11]], "date-time": "2016-11-11T19:09:56Z", "timestamp": 1478891396000}, "page": "e000043", "update-policy": "http://dx.doi.org/10.1136/crossmarkpolicy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Highlights from the San Antonio Breast Cancer Symposium 2015"], "prefix": "10.1136", "volume": "1", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "239", "published-online": {"date-parts": [[2016, 2, 26]]}, "container-title": ["ESMO Open"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/esmoopen-2016-000043", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 24]], "date-time": "2016-12-24T13:48:10Z", "timestamp": 1482587290000}, "score": 26.512724, "issued": {"date-parts": [[2016, 2]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 2, 26]]}, "published-print": {"date-parts": [[2016, 2]]}, "issue": "1"}, "alternative-id": ["10.1136/esmoopen-2016-000043"], "URL": "http://dx.doi.org/10.1136/esmoopen-2016-000043", "ISSN": ["2059-7029"], "issn-type": [{"value": "2059-7029", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T11:00:59Z", "timestamp": 1525345259727}, "reference-count": 3, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2002, 9, 1]], "date-time": "2002-09-01T00:00:00Z", "timestamp": 1030838400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Evidence-based Oncology"], "published-print": {"date-parts": [[2002, 9]]}, "DOI": "10.1054/ebon.2002.0036", "type": "journal-article", "created": {"date-parts": [[2002, 10, 28]], "date-time": "2002-10-28T17:53:31Z", "timestamp": 1035827611000}, "page": "117-119", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Alternating and sequential administration of docetaxel with fluorouracil, epirubicin and cyclophosphamide have similar safety profiles for metastatic breast cancer"], "prefix": "10.1054", "volume": "3", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Evidence-based Oncology"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S136340540290036X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S136340540290036X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2015, 9, 15]], "date-time": "2015-09-15T23:56:51Z", "timestamp": 1442361411000}, "score": 26.512724, "issued": {"date-parts": [[2002, 9]]}, "references-count": 3, "journal-issue": {"published-print": {"date-parts": [[2002, 9]]}, "issue": "3"}, "alternative-id": ["S136340540290036X"], "URL": "http://dx.doi.org/10.1054/ebon.2002.0036", "ISSN": ["1363-4054"], "issn-type": [{"value": "1363-4054", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T02:05:37Z", "timestamp": 1525399537509}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1999, 9, 1]], "date-time": "1999-09-01T00:00:00Z", "timestamp": 936144000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Lung Cancer"], "published-print": {"date-parts": [[1999, 9]]}, "DOI": "10.1016/s0169-5002(99)90701-8", "type": "journal-article", "created": {"date-parts": [[2004, 3, 24]], "date-time": "2004-03-24T10:15:30Z", "timestamp": 1080123330000}, "page": "S5", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Combined chemotherapy and radiation in NSCLC"], "prefix": "10.1016", "volume": "25", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Lung Cancer"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0169500299907018?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0169500299907018?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2015, 10, 7]], "date-time": "2015-10-07T20:40:00Z", "timestamp": 1444250400000}, "score": 26.512724, "issued": {"date-parts": [[1999, 9]]}, "references-count": 0, "alternative-id": ["S0169500299907018"], "URL": "http://dx.doi.org/10.1016/s0169-5002(99)90701-8", "ISSN": ["0169-5002"], "issn-type": [{"value": "0169-5002", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T11:00:31Z", "timestamp": 1525345231707}, "reference-count": 26, "publisher": "Elsevier BV", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2002, 12, 1]], "date-time": "2002-12-01T00:00:00Z", "timestamp": 1038700800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Lung Cancer"], "published-print": {"date-parts": [[2002, 12]]}, "DOI": "10.1016/s0169-5002(02)00267-2", "type": "journal-article", "created": {"date-parts": [[2003, 4, 7]], "date-time": "2003-04-07T18:33:56Z", "timestamp": 1049740436000}, "page": "43-46", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Combined chemotherapy and radiotherapy in inoperable non-small cell lung cancer"], "prefix": "10.1016", "volume": "38", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Lung Cancer"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0169500202002672?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0169500202002672?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 1, 12]], "date-time": "2018-01-12T09:10:32Z", "timestamp": 1515748232000}, "score": 26.512724, "issued": {"date-parts": [[2002, 12]]}, "references-count": 26, "alternative-id": ["S0169500202002672"], "URL": "http://dx.doi.org/10.1016/s0169-5002(02)00267-2", "ISSN": ["0169-5002"], "issn-type": [{"value": "0169-5002", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 11, 26]], "date-time": "2018-11-26T05:10:58Z", "timestamp": 1543209058628}, "reference-count": 4, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 3, 1]], "date-time": "2012-03-01T00:00:00Z", "timestamp": 1330560000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Lancet Oncology"], "published-print": {"date-parts": [[2012, 3]]}, "DOI": "10.1016/s1470-2045(12)70082-7", "type": "journal-article", "created": {"date-parts": [[2012, 2, 16]], "date-time": "2012-02-16T05:53:58Z", "timestamp": 1329371638000}, "page": "217-218", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Maintenance chemotherapy in advanced non-small-cell lung cancer"], "prefix": "10.1016", "volume": "13", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["The Lancet Oncology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1470204512700827?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1470204512700827?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 26]], "date-time": "2018-11-26T04:29:09Z", "timestamp": 1543206549000}, "score": 26.512724, "issued": {"date-parts": [[2012, 3]]}, "references-count": 4, "journal-issue": {"published-print": {"date-parts": [[2012, 3]]}, "issue": "3"}, "alternative-id": ["S1470204512700827"], "URL": "http://dx.doi.org/10.1016/s1470-2045(12)70082-7", "ISSN": ["1470-2045"], "issn-type": [{"value": "1470-2045", "type": "print"}], "subject": ["Oncology"]}, {"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T18:10:11Z", "timestamp": 1525371011442}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2D", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 4, 1]], "date-time": "2003-04-01T00:00:00Z", "timestamp": 1049155200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2003, 4]]}, "DOI": "10.1053/sonc.2003.37269", "type": "journal-article", "created": {"date-parts": [[2003, 4, 29]], "date-time": "2003-04-29T18:44:48Z", "timestamp": 1051641888000}, "page": "11-14", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Gemcitabine and anthracyclines in breast cancer"], "prefix": "10.1053", "volume": "30", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Seminars in Oncology"], "deposited": {"date-parts": [[2015, 9, 23]], "date-time": "2015-09-23T21:43:21Z", "timestamp": 1443044601000}, "score": 26.512724, "issued": {"date-parts": [[2003, 4]]}, "references-count": 0, "journal-issue": {"issue": "2D"}, "alternative-id": ["10.1053/sonc.2003.37269"], "URL": "http://dx.doi.org/10.1053/sonc.2003.37269", "ISSN": ["0093-7754"], "issn-type": [{"value": "0093-7754", "type": "print"}], "article-number": "asonc37269"}, {"indexed": {"date-parts": [[2018, 5, 2]], "date-time": "2018-05-02T22:31:26Z", "timestamp": 1525300286575}, "reference-count": 62, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 6, 1]], "date-time": "2001-06-01T00:00:00Z", "timestamp": 991353600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Lancet Oncology"], "published-print": {"date-parts": [[2001, 6]]}, "DOI": "10.1016/s1470-2045(00)00387-9", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T16:33:28Z", "timestamp": 1027614808000}, "page": "335-342", "source": "Crossref", "is-referenced-by-count": 25, "title": ["Combined chemotherapy and radiation in locally advanced nonsmall-cell lung cancer"], "prefix": "10.1016", "volume": "2", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["The Lancet Oncology"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S1470204500003879?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S1470204500003879?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 9, 14]], "date-time": "2017-09-14T13:37:17Z", "timestamp": 1505396237000}, "score": 26.512724, "issued": {"date-parts": [[2001, 6]]}, "references-count": 62, "journal-issue": {"published-print": {"date-parts": [[2001, 6]]}, "issue": "6"}, "alternative-id": ["S1470204500003879"], "URL": "http://dx.doi.org/10.1016/s1470-2045(00)00387-9", "ISSN": ["1470-2045"], "issn-type": [{"value": "1470-2045", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 2]], "date-time": "2018-05-02T21:59:14Z", "timestamp": 1525298354166}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 3, 1]], "date-time": "2006-03-01T00:00:00Z", "timestamp": 1141171200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer Supplements"], "published-print": {"date-parts": [[2006, 3]]}, "DOI": "10.1016/s1359-6349(06)80010-8", "type": "journal-article", "created": {"date-parts": [[2006, 5, 9]], "date-time": "2006-05-09T18:07:11Z", "timestamp": 1147198031000}, "page": "13-14", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Management of local relapse in breast cancer"], "prefix": "10.1016", "volume": "4", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer Supplements"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S1359634906800108?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S1359634906800108?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2015, 11, 21]], "date-time": "2015-11-21T21:47:43Z", "timestamp": 1448142463000}, "score": 26.512724, "issued": {"date-parts": [[2006, 3]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2006, 3]]}, "issue": "2"}, "alternative-id": ["S1359634906800108"], "URL": "http://dx.doi.org/10.1016/s1359-6349(06)80010-8", "ISSN": ["1359-6349"], "issn-type": [{"value": "1359-6349", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 4, 14]], "date-time": "2018-04-14T22:58:06Z", "timestamp": 1523746686277}, "reference-count": 0, "publisher": "VM Media SP. zo.o VM Group SK", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.5603/njo.2014.0096", "type": "journal-article", "created": {"date-parts": [[2015, 3, 20]], "date-time": "2015-03-20T08:41:31Z", "timestamp": 1426840891000}, "page": "542-543", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Czy radioterapia u chorych na raka piersi po operacji oszcz\u0119dzaj\u0105cej mo\u017ce by\u0107 jeszcze kr\u00f3tsza, ni\u017c obecnie zalecana?"], "prefix": "10.5603", "volume": "64", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "3595", "published-online": {"date-parts": [[2015, 1, 8]]}, "container-title": ["Nowotwory. Journal of Oncology"], "link": [{"URL": "https://journals.viamedica.pl/nowotwory_journal_of_oncology/article/viewFile/40707/28029", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 12, 28]], "date-time": "2017-12-28T11:59:05Z", "timestamp": 1514462345000}, "score": 26.512724, "issued": {"date-parts": [[2015, 1, 8]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2015, 1, 8]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.5603/njo.2014.0096", "ISSN": ["2300-2115", "0029-540X"], "issn-type": [{"value": "0029-540X", "type": "print"}, {"value": "2300-2115", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 4, 14]], "date-time": "2018-04-14T22:58:06Z", "timestamp": 1523746686443}, "reference-count": 0, "publisher": "VM Media SP. zo.o VM Group SK", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.5603/njo.2014.0106", "type": "journal-article", "created": {"date-parts": [[2015, 3, 20]], "date-time": "2015-03-20T08:41:31Z", "timestamp": 1426840891000}, "page": "567-568", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Zbigniew Wojtasi\u0144ski: \u201e\u017bycie z rakiem. Jadowite w\u0119\u017ce w koszyku\u201d"], "prefix": "10.5603", "volume": "64", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "3595", "published-online": {"date-parts": [[2015, 1, 8]]}, "container-title": ["Nowotwory. Journal of Oncology"], "link": [{"URL": "https://journals.viamedica.pl/nowotwory_journal_of_oncology/article/viewFile/40718/28040", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 12, 28]], "date-time": "2017-12-28T11:58:50Z", "timestamp": 1514462330000}, "score": 26.512724, "issued": {"date-parts": [[2015, 1, 8]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2015, 1, 8]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.5603/njo.2014.0106", "ISSN": ["2300-2115", "0029-540X"], "issn-type": [{"value": "0029-540X", "type": "print"}, {"value": "2300-2115", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 2]], "date-time": "2018-05-02T20:31:19Z", "timestamp": 1525293079320}, "reference-count": 28, "publisher": "Elsevier BV", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 12, 1]], "date-time": "2001-12-01T00:00:00Z", "timestamp": 1007164800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Lung Cancer"], "published-print": {"date-parts": [[2001, 12]]}, "DOI": "10.1016/s0169-5002(01)00365-8", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T09:50:45Z", "timestamp": 1027590645000}, "page": "S177-S180", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Radiotherapy for non-small cell lung cancer"], "prefix": "10.1016", "volume": "34", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Lung Cancer"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0169500201003658?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0169500201003658?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 14]], "date-time": "2017-06-14T19:05:23Z", "timestamp": 1497467123000}, "score": 26.512724, "issued": {"date-parts": [[2001, 12]]}, "references-count": 28, "alternative-id": ["S0169500201003658"], "URL": "http://dx.doi.org/10.1016/s0169-5002(01)00365-8", "ISSN": ["0169-5002"], "issn-type": [{"value": "0169-5002", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 2]], "date-time": "2018-05-02T20:31:19Z", "timestamp": 1525293079362}, "reference-count": 23, "publisher": "Elsevier BV", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2001, 12, 1]], "date-time": "2001-12-01T00:00:00Z", "timestamp": 1007164800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Lung Cancer"], "published-print": {"date-parts": [[2001, 12]]}, "DOI": "10.1016/s0169-5002(01)00366-x", "type": "journal-article", "created": {"date-parts": [[2002, 7, 25]], "date-time": "2002-07-25T09:50:45Z", "timestamp": 1027590645000}, "page": "S181-S183", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Combined modality treatment with chemotherapy and radiation in locally advanced non-small cell lung cancer"], "prefix": "10.1016", "volume": "34", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Lung Cancer"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S016950020100366X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S016950020100366X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 8, 25]], "date-time": "2017-08-25T01:30:08Z", "timestamp": 1503624608000}, "score": 26.512724, "issued": {"date-parts": [[2001, 12]]}, "references-count": 23, "alternative-id": ["S016950020100366X"], "URL": "http://dx.doi.org/10.1016/s0169-5002(01)00366-x", "ISSN": ["0169-5002"], "issn-type": [{"value": "0169-5002", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T14:28:24Z", "timestamp": 1525357704601}, "reference-count": 17, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "http://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2003, 1, 1]], "date-time": "2003-01-01T00:00:00Z", "timestamp": 1041379200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Current Problems in Cancer"], "published-print": {"date-parts": [[2003, 1]]}, "DOI": "10.1067/mcn.2003.11", "type": "journal-article", "created": {"date-parts": [[2003, 2, 5]], "date-time": "2003-02-05T05:48:50Z", "timestamp": 1044424130000}, "page": "64-68", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Role of chemotherapy in the multimodality approach of non-small cell lung cancer"], "prefix": "10.1067", "volume": "27", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Current Problems in Cancer"], "language": "en", "link": [{"URL": "http://api.elsevier.com/content/article/PII:S0147027202000132?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.elsevier.com/content/article/PII:S0147027202000132?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 1, 29]], "date-time": "2018-01-29T09:12:02Z", "timestamp": 1517217122000}, "score": 26.512724, "issued": {"date-parts": [[2003, 1]]}, "references-count": 17, "journal-issue": {"published-print": {"date-parts": [[2003, 1]]}, "issue": "1"}, "alternative-id": ["S0147027202000132"], "URL": "http://dx.doi.org/10.1067/mcn.2003.11", "ISSN": ["0147-0272"], "issn-type": [{"value": "0147-0272", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 6, 8]], "date-time": "2018-06-08T04:33:51Z", "timestamp": 1528432431686}, "reference-count": 14, "publisher": "Future Medicine Ltd", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Future Oncology"], "published-print": {"date-parts": [[2006, 10]]}, "DOI": "10.2217/14796694.2.5.569", "type": "journal-article", "created": {"date-parts": [[2006, 10, 9]], "date-time": "2006-10-09T11:54:49Z", "timestamp": 1160394889000}, "page": "569-571", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Postoperative chemotherapy in non-small cell lung cancer: still more questions than answers"], "prefix": "10.2217", "volume": "2", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "1057", "reference": [{"key": "ref-1", "DOI": "10.1016/S0140-6736(98)06341-7", "doi-asserted-by": "publisher"}, {"key": "ref-2", "DOI": "10.1136/bmj.311.7010.899", "doi-asserted-by": "publisher"}, {"key": "ref-3", "DOI": "10.1056/NEJM200010263431703", "doi-asserted-by": "publisher"}, {"key": "ref-4", "DOI": "10.1093/jnci/djg059", "doi-asserted-by": "publisher"}, {"key": "ref-5", "DOI": "10.1056/NEJMoa031644", "doi-asserted-by": "publisher"}, {"key": "ref-6", "DOI": "10.1056/NEJMoa043623", "doi-asserted-by": "publisher"}, {"key": "ref-7", "author": "Douillard", "year": "2005", "volume-title": "Proceedings of the Annual Meeting of the American Society of Clinical Oncology."}, {"key": "ref-8", "author": "Strauss", "year": "2004", "volume-title": "Proceedings of the Annual Meeting of the American Society of Clinical Oncology."}, {"key": "ref-9", "author": "Pignon", "year": "2006", "volume-title": "Proceedings of the Annual Meeting of the American Society of Clinical Oncology."}, {"key": "ref-10", "author": "Strauss", "year": "2006", "volume-title": "Proceedings of the Annual Meeting of the American Society of Clinical Oncology."}, {"key": "ref-11", "DOI": "10.1200/JCO.2004.02.109", "doi-asserted-by": "publisher"}, {"key": "ref-12", "author": "Ardizzoni", "year": "2006", "volume-title": "Proceedings of the Annual Meeting of the American Society of Clinical Oncology."}, {"key": "ref-13", "author": "Pepe", "year": "2006", "volume-title": "Proccedings of the Annual Meeting of the American Society of Clinical Oncology."}, {"key": "ref-14", "unstructured": "OlaussenKA, Dunant A, Fouret Pet\u00a0al.: DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.N.\u00a0Engl. J. Med.355(10),983\u2013991 (2006).", "DOI": "10.1056/NEJMoa060570", "doi-asserted-by": "crossref"}], "container-title": ["Future Oncology"], "language": "en", "deposited": {"date-parts": [[2018, 6, 7]], "date-time": "2018-06-07T17:56:56Z", "timestamp": 1528394216000}, "score": 26.512724, "issued": {"date-parts": [[2006, 10]]}, "references-count": 14, "journal-issue": {"published-print": {"date-parts": [[2006, 10]]}, "issue": "5"}, "alternative-id": ["10.2217/14796694.2.5.569"], "URL": "http://dx.doi.org/10.2217/14796694.2.5.569", "relation": {"cites": []}, "ISSN": ["1479-6694", "1744-8301"], "issn-type": [{"value": "1479-6694", "type": "print"}, {"value": "1744-8301", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 3]], "date-time": "2018-05-03T23:04:59Z", "timestamp": 1525388699678}, "reference-count": 41, "publisher": "Springer Nature", "issue": "S1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Breast Cancer Res Treat"], "published-print": {"date-parts": [[2003, 3]]}, "DOI": "10.1023/a:1026312705693", "type": "journal-article", "created": {"date-parts": [[2003, 11, 4]], "date-time": "2003-11-04T00:30:08Z", "timestamp": 1067905808000}, "page": "37-42", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Chemotherapy of Metastatic Breast Cancer: Is more better?"], "prefix": "10.1007", "volume": "81", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "5143716_CR1", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1007/BF01806548", "volume": "13", "author": "R Mick", "year": "1989", "unstructured": "Mick R, Begg CB, Antman K et al.: Diverse prognosis in metastatic breast cancer: who should be offered alternative initial therapies? Breast Cancer Res Treat 13: 33-38, 1989", "journal-title": "Breast Cancer Res Treat"}, {"key": "5143716_CR2", "doi-asserted-by": "crossref", "first-page": "1571", "DOI": "10.1093/jnci/88.21.1571", "volume": "88", "author": "KC Chu", "year": "1996", "unstructured": "Chu KC, Tarone RE, Kessler LG et al.: Recent trends in US breast cancer incidence, survival and mortality rates. J Natl Cancer Inst 88: 1571\u20131579, 1996", "journal-title": "J Natl Cancer Inst"}, {"key": "5143716_CR3", "doi-asserted-by": "crossref", "first-page": "2197", "DOI": "10.1200/JCO.1996.14.8.2197", "volume": "14", "author": "PA Greenberg", "year": "1996", "unstructured": "Greenberg PA, Hortobagyi GN, Smith TL et al.: Long term follow up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol 14: 2197\u20132205, 1996", "journal-title": "J Clin Oncol"}, {"key": "5143716_CR4", "first-page": "1", "volume": "35", "author": "HE Skipper", "year": "1964", "unstructured": "Skipper HE, Schabel FM, Jary R et al.: Experimental evaluation of antitumour agents. Cancer Chemother Rep 35: 1\u201334, 1964", "journal-title": "Cancer Chemother Rep"}, {"key": "5143716_CR5", "first-page": "329", "volume": "6", "author": "B Hoogstraten", "year": "1975", "unstructured": "Hoogstraten B: Adriamycin (NSC-123127) in the treatment of advanced breast cancer: studies by Southwest Oncology Group. Cancer Chemother Rep 6: 329\u2013339, 1975", "journal-title": "Cancer Chemother Rep"}, {"key": "5143716_CR6", "doi-asserted-by": "crossref", "first-page": "585", "DOI": "10.1016/0002-9343(80)90472-6", "volume": "69", "author": "E Frei", "year": "1980", "unstructured": "Frei E, Canellos OGP: Dose: a critical factor in cancer chemotherapy. Am J Med 69: 585\u2013594, 1980", "journal-title": "Am J Med"}, {"key": "5143716_CR7", "unstructured": "O'Bryan RM, Baker LH, Gottlieb JE et al.: Dose response evaluation of adriamycin in human neoplasia. Cancer 39: 1940\u20131948, 1977", "DOI": "10.1002/1097-0142(197705)39:5<1940::AID-CNCR2820390505>3.0.CO;2-0", "doi-asserted-by": "crossref"}, {"key": "5143716_CR8", "first-page": "1160", "volume": "50", "author": "FM Schabel Jr", "year": "1980", "unstructured": "Schabel Jr FM, Grinswold DP, Corbett TH et al.: Increasing the therapeutic response rate to anticancer drugs by applying the basic principles of pharmacology. Cancer 50: 1160\u20131167, 1980", "journal-title": "Cancer"}, {"key": "5143716_CR9", "author": "TA Gilewski", "first-page": "751", "year": "1996", "unstructured": "Gilewski TA, Norton L: Cytokines and breast cancer chemotherapy. In: Harris JR, Lippman ME, Morrow M et al. (eds) Disease of the Breast. Lippincot-Raven, Philadelphia, 1996, pp 751\u2013768", "volume-title": "Disease of the Breast"}, {"key": "5143716_CR10", "first-page": "101a", "volume": "17", "author": "I Henderson", "year": "1998", "unstructured": "Henderson I, Berry D, Demetri G et al.: Improved disease-free and overall survival from the addition of sequential paclitaxel but not from the escalation of doxorubicin dose level in the Chemotherapy of metastatic breast cancer S41 adjuvant chemotherapy of patients with node-positive primary breast cancer. Proc ASCO 17: 101a, 1998", "journal-title": "Proc ASCO"}, {"key": "5143716_CR11", "doi-asserted-by": "crossref", "first-page": "1281", "DOI": "10.1200/JCO.1984.2.11.1281", "volume": "2", "author": "W Hryniuk", "year": "1984", "unstructured": "Hryniuk W, Bush H: The importance of dose intensity in chemotherapy of breast cancer. J Clin Oncol 2: 1281\u20131288, 1984", "journal-title": "J Clin Oncol"}, {"key": "5143716_CR12", "first-page": "232", "volume": "77", "author": "G Fountizilas", "year": "1991", "unstructured": "Fountizilas G, Skarlos D, Pavlidis N et al.: High dose epirubicin as a single agent in the treatment of patients with advanced breast cancer. A Hellenic Cooperative Oncology Group Study. Tumori 77: 232\u2013236, 1991", "journal-title": "Tumori"}, {"key": "5143716_CR13", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1007/BF00685824", "volume": "28", "author": "P Jacobsen", "year": "1991", "unstructured": "Jacobsen P, Basholt L, Dalmark M et al.: A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood sample measurement. Cancer Chemother Pharmacol 28: 465\u2013469, 1991", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "5143716_CR14", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1002/1097-0142(197607)38:1<13::AID-CNCR2820380104>3.0.CO;2-5", "volume": "38", "author": "B Hoogstraten", "year": "1976", "unstructured": "Hoogstraten B, George SL, Samal B et al.: Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study. Cancer 38: 13\u201320, 1976", "journal-title": "Cancer"}, {"key": "5143716_CR15", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.1038/bjc.1987.226", "volume": "56", "author": "J Carmo-Pereira", "year": "1987", "unstructured": "Carmo-Pereira J, Costa FO, Henriquez E et al.: A comparison of two doses of Adriamycin in the primary chemotherapy of disseminated breast carcinoma. Br J Cancer 56: 471\u2013473, 1987", "journal-title": "Br J Cancer"}, {"key": "5143716_CR16", "doi-asserted-by": "crossref", "first-page": "1253", "DOI": "10.1200/JCO.1993.11.7.1253", "volume": "11", "author": "C Focan", "year": "1993", "unstructured": "Focan C, Andien JM, Closon MT et al.: Dose-response relationship of epirubicin-based first-line chemotherapy for advanced breast cancer: a prospective randomized trial. J Clin Oncol 11: 1253\u20131263, 1993", "journal-title": "J Clin Oncol"}, {"key": "5143716_CR17", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1200/JCO.1991.9.2.295", "volume": "9", "author": "T Habeshaw", "year": "1991", "unstructured": "Habeshaw T, Paul J, Jones R et al.: Epirubicin at two dose levels with prednisolone as treatment of advanced breast cancer. Results of a randomised trial. J Clin Oncol 9: 295\u2013304, 1991", "journal-title": "J Clin Oncol"}, {"key": "5143716_CR18", "doi-asserted-by": "crossref", "first-page": "1377", "DOI": "10.1200/JCO.1988.6.9.1377", "volume": "6", "author": "IF Tannock", "year": "1988", "unstructured": "Tannock IF, Boyd NF, De Boer G et al.: A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer. J Clin Oncol 6: 1377\u20131387, 1988", "journal-title": "J Clin Oncol"}, {"key": "5143716_CR19", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1016/S0960-9776(97)90613-5", "volume": "6", "author": "P Malmstrom", "year": "1997", "unstructured": "Malmstrom P, Malmberg M, Jonsson PE et al.: A dose intensity study of epirubicin weekly for disseminated breast cancer. Breast 6: 233\u2013234, 1997", "journal-title": "Breast"}, {"key": "5143716_CR20", "doi-asserted-by": "crossref", "first-page": "1449", "DOI": "10.1056/NEJM198911233212106", "volume": "321", "author": "JE Groopman", "year": "1989", "unstructured": "Groopman JE, Molina JM, Scadden DT: Haemopoietic growth factors: biology and clinical applications. N Engl J Med 321: 1449\u20131459, 1989", "journal-title": "N Engl J Med"}, {"key": "5143716_CR21", "first-page": "362", "volume": "4", "author": "GD Demetri", "year": "1992", "unstructured": "Demetri GD, Antman KH: Granulocyte macrophage colonystimulating factor (GM-CSF): preclinical and clinical investigations. Semin Oncol 4: 362\u2013385, 1992", "journal-title": "Semin Oncol"}, {"key": "5143716_CR22", "doi-asserted-by": "crossref", "first-page": "487", "DOI": "10.1007/s002800050516", "volume": "38", "author": "M Venturini", "year": "1996", "unstructured": "Venturini M, Del Mastro L, Testore F et al.: Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/ epidoxorubicin/5-fluorouracil chemotherapy: a dose-finding study in patients with advanced breast cancer. Cancer Chemother Pharmacol 38: 487\u2013494, 1996", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "5143716_CR23", "doi-asserted-by": "crossref", "first-page": "673", "DOI": "10.1093/oxfordjournals.annonc.a059283", "volume": "6", "author": "M Piccart", "year": "1995", "unstructured": "Piccart M, Bruning P, Wildiers J et al.: An EORTC pilot study of filgrastim (recombinant human granulocyte colony stimulating factor) as support to a high dose-intensive epiadriamycin-cyclophosphamide regimen in chemotherapynaive patients with locally advanced or metastatic breast cancer. Ann Oncol 6: 673\u2013677, 1995", "journal-title": "Ann Oncol"}, {"key": "5143716_CR24", "doi-asserted-by": "crossref", "first-page": "385", "DOI": "10.1038/bjc.1994.71", "volume": "69", "author": "A Arridzzoni", "year": "1994", "unstructured": "Arridzzoni A, Venturini M, Sertoli MR et al.: Granulocytemacrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer. Br J Cancer 69: 385\u2013391, 1994", "journal-title": "Br J Cancer"}, {"key": "5143716_CR25", "doi-asserted-by": "crossref", "first-page": "482", "DOI": "10.1016/S0959-8049(97)10039-9", "volume": "34", "author": "H Stoger", "year": "1998", "unstructured": "Stoger H, Samonigg H, Krainer M et al.: Dose intensification of epidoxorubicin and cyclophosphamide in metastatic breast cancer: a randomized study with two schedules of granulocyte-macrophage colony stimulating factor. Eur J Cancer 34: 482\u2013488, 1998", "journal-title": "Eur J Cancer"}, {"key": "5143716_CR26", "doi-asserted-by": "crossref", "first-page": "1213", "DOI": "10.1023/A:1008270307264", "volume": "8", "author": "G Fountzilas", "year": "1997", "unstructured": "Fountzilas G, Athanassiades A, Giannakakis T et al.: A randomised study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study. Ann Oncol 8: 1213\u20131220, 1997", "journal-title": "Ann Oncol"}, {"key": "5143716_CR27", "doi-asserted-by": "crossref", "first-page": "2213", "DOI": "10.1200/JCO.2001.19.8.2213", "volume": "19", "author": "L Del Mastro", "year": "2001", "unstructured": "Del Mastro L, Venturini M, Lionetto R et al.: Acceleratedintensified cyclophosphamide, epirubicin and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: results of a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group. J Clin Oncol 19: 2213\u20132221, 2001", "journal-title": "J Clin Oncol"}, {"key": "5143716_CR28", "unstructured": "Therasse PL, Mauriac L, We?nicka-Ja\u00b4skiewicz M et al.: Final results of a randomized phase III trial comparing CEF (Cyclophosphamide, Epirubicin, 5FU) with a dose-intensified EC+G-CSF (Epirubicin, Cyclophosphamide +Filgrastim) as neo-adjuvant treatment in locally advanced breast cancer. An EORTC-NCIC-SAKK multicenter study. J Clin Oncol (in press)"}, {"key": "5143716_CR29", "doi-asserted-by": "crossref", "first-page": "3558", "DOI": "10.1200/JCO.2000.18.20.3558", "volume": "18", "author": "H Ozer", "year": "2000", "unstructured": "Ozer H, Armitage JO, Bennett CL et al.: ASCO special article. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 18: 3558\u20133585, 2000", "journal-title": "J Clin Oncol"}, {"key": "5143716_CR30", "doi-asserted-by": "crossref", "first-page": "3439", "DOI": "10.1200/JCO.1998.16.10.3439", "volume": "16", "author": "R Fossati", "year": "1998", "unstructured": "Fossati R, Torri V, Ghislandi TE et al.: Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. J Clin Oncol 16: 3439\u20133460, 1998", "journal-title": "J Clin Oncol"}, {"key": "5143716_CR31", "doi-asserted-by": "crossref", "first-page": "1858", "DOI": "10.1200/JCO.1996.14.6.1858", "volume": "14", "author": "JM Nabholtz", "year": "1996", "unstructured": "Nabholtz JM, Gelmon K, Bontenbal M et al.: Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer. J Clin Oncol 14: 1858\u20131867, 1996", "journal-title": "J Clin Oncol"}, {"key": "5143716_CR32", "first-page": "101a", "volume": "17", "author": "E Winer", "year": "1998", "unstructured": "Winer E, Berry D, Duggan D et al.: Failure of higher dose paclitaxel to improve outcome in patients with metastatic breast cancer-results from CALBG 9342. Proc ASCO 17: 101a, 1998 (abstrakt).", "journal-title": "Proc ASCO"}, {"issue": "1", "key": "5143716_CR33", "first-page": "S88", "volume": "76", "author": "H Mouridsen", "year": "2002", "unstructured": "Mouridsen H, Harvey V, Semoglazov V et al.: Phase III study of docetaxel 100 versus 75 versus 60mg/m2 as a second line chemotherapy in advanced breast cancer. Breast Cancer Res Treat 76(1): S88, 2002", "journal-title": "Breast Cancer Res Treat"}, {"key": "5143716_CR34", "doi-asserted-by": "crossref", "first-page": "3374", "DOI": "10.1200/JCO.1999.17.11.3374", "volume": "17", "author": "B Fischer", "year": "1999", "unstructured": "Fischer B, Anderson S, DeCillis A et al.: Further evaluation of intensifies and increased total dose of cyclophosphamide for the treatment of primary breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-25. J Clin Oncol 17: 3374\u20133388, 1999", "journal-title": "J Clin Oncol"}, {"key": "5143716_CR35", "doi-asserted-by": "crossref", "first-page": "1858", "DOI": "10.1200/JCO.1997.15.5.1858", "volume": "15", "author": "B Fischer", "year": "1997", "unstructured": "Fischer B, Anderson S, Wickerham D et al.: Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Adjuvant Breast and Bowel Project B-25. J Clin Oncol 15: 1858\u20131869, 1997", "journal-title": "J Clin Oncol"}, {"key": "5143716_CR36", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1016/S0305-7372(98)90048-2", "volume": "24", "author": "M Clemons", "year": "1998", "unstructured": "Clemons M, Gharif R, Howell A: The value of dose intensification of standard chemotherapy for advanced breast cancer using colony-stimulating factors alone. Cancer Treat Rev 24: 173\u2013184, 1998", "journal-title": "Cancer Treat Rev"}, {"key": "5143716_CR37", "doi-asserted-by": "crossref", "first-page": "2981", "DOI": "10.1200/JCO.1997.15.8.2981", "volume": "15", "author": "DMF Savarese", "year": "1977", "unstructured": "Savarese DMF, Hsieh C, Stewart FM: Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors. J Clin Oncol 15: 2981\u20132995, 1977", "journal-title": "J Clin Oncol"}, {"key": "5143716_CR38", "first-page": "1253", "volume": "11", "author": "French Epirubicin Study Group", "year": "1991", "unstructured": "French Epirubicin Study Group: a Prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients. J Clin Oncol 11: 1253\u20131263, 1991", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "5143716_CR39", "first-page": "10", "volume": "21", "author": "N Marschner", "year": "1994", "unstructured": "Marschner N, Krelenberg R, Souchon R et al.: Evaluation of the importance and relevance of dose intensity using epirubicin and cyclophosphamide in metastatic breast cancer. Interim analysis of a prospective randomized trial. Semin Oncol 21(1): 10\u201316, 1994", "journal-title": "Semin Oncol"}, {"key": "5143716_CR40", "doi-asserted-by": "crossref", "first-page": "1146", "DOI": "10.1200/JCO.1996.14.4.1146", "volume": "14", "author": "L Bastholt", "year": "1996", "unstructured": "Bastholt L, Dalmark M, Gjedde SB et al.: Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group. J Clin Oncol 14: 1146\u20131155, 1996", "journal-title": "J Clin Oncol"}, {"key": "5143716_CR41", "doi-asserted-by": "crossref", "first-page": "155", "DOI": "10.1023/A:1008295427877", "volume": "8", "author": "G Brufman", "year": "1997", "unstructured": "Brufman G, Calajori E, Ghilezan N et al.: Doubling epirubicin dose-intensity (100mg/m2 versus 50mg/m2) in the FEC regimen significantly increases response rate. An international randomised phase III study in metastatic breast cancer. Ann Oncol 8: 155\u2013162, 1997", "journal-title": "Ann Oncol"}], "container-title": ["Breast Cancer Research and Treatment"], "language": "en", "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1023/A:1026312705693", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 3, 20]], "date-time": "2018-03-20T22:14:55Z", "timestamp": 1521584095000}, "score": 26.512724, "issued": {"date-parts": [[2003, 3]]}, "references-count": 41, "journal-issue": {"published-print": {"date-parts": [[2003, 3]]}, "issue": "S1"}, "alternative-id": ["5143716"], "URL": "http://dx.doi.org/10.1023/a:1026312705693", "relation": {"cites": []}, "ISSN": ["0167-6806", "1573-7217"], "issn-type": [{"value": "0167-6806", "type": "print"}, {"value": "1573-7217", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T07:25:19Z", "timestamp": 1525418719161}, "reference-count": 7, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "Supplement 1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Anti-Cancer Drugs"], "published-print": {"date-parts": [[2008, 2]]}, "DOI": "10.1097/01.cad.0000277608.23376.bc", "type": "journal-article", "created": {"date-parts": [[2008, 3, 13]], "date-time": "2008-03-13T07:01:25Z", "timestamp": 1205391685000}, "page": "S3-S7", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Intergroup Exemestane Study mature analysis: overall survival data"], "prefix": "10.1097", "volume": "19", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["Anti-Cancer Drugs"], "language": "en", "deposited": {"date-parts": [[2018, 2, 8]], "date-time": "2018-02-08T16:39:43Z", "timestamp": 1518107983000}, "score": 26.512724, "subtitle": [""], "issued": {"date-parts": [[2008, 2]]}, "references-count": 7, "journal-issue": {"issue": "Supplement 1"}, "URL": "http://dx.doi.org/10.1097/01.cad.0000277608.23376.bc", "ISSN": ["0959-4973"], "issn-type": [{"value": "0959-4973", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T07:25:18Z", "timestamp": 1525418718893}, "reference-count": 7, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "Supplement 1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Anti-Cancer Drugs"], "published-print": {"date-parts": [[2008, 2]]}, "DOI": "10.1097/01.cad.0000277607.85258.de", "type": "journal-article", "created": {"date-parts": [[2008, 3, 13]], "date-time": "2008-03-13T07:01:25Z", "timestamp": 1205391685000}, "page": "S1", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Exemestane: an alternative treatment option in early breast cancer"], "prefix": "10.1097", "volume": "19", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "276", "container-title": ["Anti-Cancer Drugs"], "language": "en", "deposited": {"date-parts": [[2018, 2, 8]], "date-time": "2018-02-08T16:39:42Z", "timestamp": 1518107982000}, "score": 26.512724, "subtitle": [""], "issued": {"date-parts": [[2008, 2]]}, "references-count": 7, "journal-issue": {"issue": "Supplement 1"}, "URL": "http://dx.doi.org/10.1097/01.cad.0000277607.85258.de", "ISSN": ["0959-4973"], "issn-type": [{"value": "0959-4973", "type": "print"}]}, {"indexed": {"date-parts": [[2018, 5, 4]], "date-time": "2018-05-04T12:58:37Z", "timestamp": 1525438717563}, "reference-count": 36, "publisher": "Informa UK Limited", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Expert Review of Anticancer Therapy"], "published-print": {"date-parts": [[2002, 8]]}, "DOI": "10.1586/14737140.2.4.402", "type": "journal-article", "created": {"date-parts": [[2005, 1, 13]], "date-time": "2005-01-13T12:53:41Z", "timestamp": 1105620821000}, "page": "402-407", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Chemoradiotherapy of nonsmall cell lung cancer"], "prefix": "10.1586", "volume": "2", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2014, 1, 10]]}, "reference": [{"issue": "49", "key": "CIT0001", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.3322/canjclin.49.1.33", "volume": "1", "author": "Parkin DM", "year": "1999", "journal-title": "CA Cancer"}, {"key": "CIT0002", "author": "Ihde DC", "volume": "15", "first-page": "61", "year": "1991", "journal-title": "I. Biology, diagnosis and staging. Cur Pro& Cancer"}, {"key": "CIT0003", "author": "Jassem J", "volume": "34", "first-page": "S177\u2014S180", "year": "2001", "journal-title": "Lung Cancer"}, {"key": "CIT0004", "author": "van Houtte P", "volume": "41", "first-page": "131", "year": "1988", "journal-title": "A randomised study. Antibiot. Chemother", "DOI": "10.1159/000416193", "doi-asserted-by": "crossref"}, {"key": "CIT0005", "author": "Mattson K", "volume": "24", "first-page": "477", "year": "1988", "journal-title": "Eur .j Cancer Clin. Oncol"}, {"key": "CIT0006", "author": "Morton RF", "volume": "115", "first-page": "681", "year": "1991", "journal-title": "Ann. Intern. Med"}, {"key": "CIT0007", "author": "Trovo MG", "volume": "65", "first-page": "400", "year": "1990", "journal-title": "A randomized study. Cancer"}, {"key": "CIT0009", "author": "Gregor A", "volume": "85", "first-page": "997", "year": "1993", "journal-title": "j Nall Cancer Inst", "DOI": "10.1093/jnci/85.12.997", "doi-asserted-by": "crossref"}, {"key": "CIT0010", "author": "Planting A", "volume": "7", "first-page": "139", "year": "1996", "journal-title": "An EORTC Lung Cancer Co-operative Group trial. Ann. Oncol"}, {"key": "CIT0011", "author": "Crino L", "volume": "4", "first-page": "847", "year": "1993", "journal-title": "Ann. Oncol"}, {"key": "CIT0015", "author": "Mattson K", "volume": "24", "first-page": "477", "year": "1988", "journal-title": "Eur j Cancer Clin. Oncol", "DOI": "10.1016/S0277-5379(98)90020-7", "doi-asserted-by": "crossref"}, {"key": "CIT0016", "author": "Morton RF", "volume": "115", "first-page": "681", "year": "1991", "journal-title": "Ann. Intern Med", "DOI": "10.7326/0003-4819-115-9-681", "doi-asserted-by": "crossref"}, {"key": "CIT0017", "author": "Arriagada R", "volume": "16", "first-page": "446a", "year": "1997", "journal-title": "Proc. Am. Soc. Clin. Oncol"}, {"key": "CIT0018", "author": "Dillman RO", "volume": "88", "first-page": "1210", "year": "1996", "journal-title": "Nati Cancer Inst", "DOI": "10.1093/jnci/88.17.1210", "doi-asserted-by": "crossref"}, {"key": "CIT0019", "author": "Sause W", "volume": "117", "first-page": "358", "year": "2000", "journal-title": "Chest", "DOI": "10.1378/chest.117.2.358", "doi-asserted-by": "crossref"}, {"key": "CIT0021", "author": "Brodin O", "volume": "32", "first-page": "1893", "year": "1996", "journal-title": "Eur J Cancer", "DOI": "10.1016/0959-8049(96)00212-2", "doi-asserted-by": "crossref"}, {"key": "CIT0022", "author": "Cullen MET", "volume": "17", "first-page": "3188", "year": "1999", "journal-title": "Clin. Oncol"}, {"key": "CIT0023", "author": "Schaake-Koning C", "volume": "326", "first-page": "524", "year": "1992", "journal-title": "Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl. J. Med"}, {"key": "CIT0025", "author": "Trovo NG", "volume": "24", "first-page": "11", "year": "1992", "journal-title": "Int. J Radiat. Oncol Biol. Phys", "DOI": "10.1016/0360-3016(92)91014-E", "doi-asserted-by": "crossref"}, {"key": "CIT0026", "author": "Ball D", "volume": "52", "first-page": "129", "year": "1999", "journal-title": "Radiother. Oncol", "DOI": "10.1016/S0167-8140(99)00093-6", "doi-asserted-by": "crossref"}, {"key": "CIT0029", "author": "Blanke C", "volume": "13", "first-page": "1425", "year": "1995", "journal-title": "Clin. Oncol", "DOI": "10.1200/JCO.1995.13.6.1425", "doi-asserted-by": "crossref"}, {"key": "CIT0030", "author": "Trovo MG", "volume": "65", "first-page": "400", "year": "1990", "journal-title": "A randomized study. Cancer"}, {"key": "CIT0031", "author": "Jeremic B", "volume": "13", "first-page": "452", "year": "1995", "journal-title": "j Clin. Oncol"}, {"key": "CIT0032", "author": "Jeremic B", "volume": "14", "first-page": "1065", "year": "1996", "journal-title": "Clin. Oncol"}, {"key": "CIT0034", "author": "Jeremic B", "volume": "71", "first-page": "3732", "year": "1993", "journal-title": "Cancer", "DOI": "10.1002/1097-0142(19930601)71:11<3732::AID-CNCR2820711142>3.0.CO;2-P", "doi-asserted-by": "crossref"}, {"key": "CIT0039", "author": "Zatloukal PV", "volume": "21", "first-page": "291a", "year": "2002", "journal-title": "A randomized Phase II study. Proc. Am Soc. Clin. awl"}, {"key": "CIT0040", "author": "Choy H", "volume": "22", "first-page": "70", "year": "1995", "journal-title": "Semin. Oncol"}, {"key": "CIT0041", "author": "Mason IKA", "volume": "3", "first-page": "2431", "year": "1997", "journal-title": "Clin. Cancer Res"}, {"key": "CIT0042", "author": "Koukourakis MI", "volume": "80", "first-page": "1792", "year": "1999", "journal-title": "Br. Cancer", "DOI": "10.1038/sj.bjc.6690599", "doi-asserted-by": "crossref"}, {"key": "CIT0043", "author": "Choy H", "volume": "4", "first-page": "1931", "year": "1998", "journal-title": "Clin. Cancer Res"}, {"key": "CIT0044", "author": "Goor C", "volume": "7", "first-page": "101", "year": "1996", "journal-title": "Ann. Oncol"}, {"key": "CIT0048", "author": "Jassem J", "volume": "2", "first-page": "335", "year": "2001", "journal-title": "Lancet Oncol", "DOI": "10.1016/S1470-2045(00)00387-9", "doi-asserted-by": "crossref"}, {"key": "CIT0049", "author": "American Society of Clinical Oncology", "volume": "15", "first-page": "2996", "year": "1997", "journal-title": "J. Clin. Oncol"}, {"key": "CIT0050", "author": "Miller EM", "volume": "51", "first-page": "1687", "year": "1992", "journal-title": "Cancer Res"}, {"key": "CIT0052", "author": "Cohen-Jonathan E", "volume": "154", "first-page": "125", "year": "2000", "journal-title": "Racliat. Res"}, {"key": "CIT0053", "author": "Mauceri HJ", "volume": "394", "first-page": "287", "year": "1998", "journal-title": "Nature", "DOI": "10.1038/28412", "doi-asserted-by": "crossref"}], "container-title": ["Expert Review of Anticancer Therapy"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1586/14737140.2.4.402", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 16]], "date-time": "2017-06-16T14:53:16Z", "timestamp": 1497624796000}, "score": 26.512724, "issued": {"date-parts": [[2002, 8]]}, "references-count": 36, "journal-issue": {"published-online": {"date-parts": [[2014, 1, 10]]}, "published-print": {"date-parts": [[2002, 8]]}, "issue": "4"}, "alternative-id": ["10.1586/14737140.2.4.402"], "URL": "http://dx.doi.org/10.1586/14737140.2.4.402", "relation": {"cites": []}, "ISSN": ["1473-7140", "1744-8328"], "issn-type": [{"value": "1473-7140", "type": "print"}, {"value": "1744-8328", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T03:58:49Z", "timestamp": 1525751929942}, "reference-count": 0, "publisher": "VM Media SP. zo.o VM Group SK", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.5603/njo.2013.0034", "type": "journal-article", "created": {"date-parts": [[2013, 12, 11]], "date-time": "2013-12-11T15:32:20Z", "timestamp": 1386775940000}, "page": "382-382", "source": "Crossref", "is-referenced-by-count": 0, "title": ["List otwarty Przewodnicz\u0105cego Zarz\u0105du G\u0142\u00f3wnego Polskiego Towarzystwa Onkologicznego"], "prefix": "10.5603", "volume": "63", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "3595", "published-online": {"date-parts": [[2013, 10, 25]]}, "container-title": ["Nowotwory. Journal of Oncology"], "link": [{"URL": "https://journals.viamedica.pl/nowotwory_journal_of_oncology/article/viewFile/36043/26034", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 12, 28]], "date-time": "2017-12-28T12:01:57Z", "timestamp": 1514462517000}, "score": 26.512724, "issued": {"date-parts": [[2013, 10, 25]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2013, 10, 25]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.5603/njo.2013.0034", "ISSN": ["2300-2115", "0029-540X"], "issn-type": [{"value": "0029-540X", "type": "print"}, {"value": "2300-2115", "type": "electronic"}]}, {"indexed": {"date-parts": [[2018, 5, 8]], "date-time": "2018-05-08T14:10:16Z", "timestamp": 1525788616125}, "reference-count": 0, "publisher": "Towarzystwo Internistow Polskich/Polish Society of Internal Medicine", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2016, 5, 5]]}, "DOI": "10.20452/pamw.3403", "type": "journal-article", "created": {"date-parts": [[2016, 6, 9]], "date-time": "2016-06-09T05:44:20Z", "timestamp": 1465451060000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Bright and dark sides of evidence-based medicine"], "prefix": "10.20452", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "8469", "container-title": ["Polish Archives of Internal Medicine"], "link": [{"URL": "http://pamw.pl/sites/default/files/inv_rev_Jassem.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 6, 9]], "date-time": "2016-06-09T05:44:20Z", "timestamp": 1465451060000}, "score": 26.512724, "issued": {"date-parts": [[2016, 5, 5]]}, "references-count": 0, "URL": "http://dx.doi.org/10.20452/pamw.3403", "ISSN": ["1897-9483"], "issn-type": [{"value": "1897-9483", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 1, 7]], "date-time": "2019-01-07T01:10:27Z", "timestamp": 1546823427527}, "reference-count": 9, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2007, 6, 1]], "date-time": "2007-06-01T00:00:00Z", "timestamp": 1180656000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Lancet Oncology"], "published-print": {"date-parts": [[2007, 6]]}, "DOI": "10.1016/s1470-2045(07)70154-7", "type": "journal-article", "created": {"date-parts": [[2007, 5, 31]], "date-time": "2007-05-31T14:01:53Z", "timestamp": 1180620113000}, "page": "461-463", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Chemotherapy for advanced NSCLC: any light at the end of the tunnel?"], "prefix": "10.1016", "volume": "8", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["The Lancet Oncology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1470204507701547?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1470204507701547?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 7]], "date-time": "2019-01-07T00:51:13Z", "timestamp": 1546822273000}, "score": 26.512724, "issued": {"date-parts": [[2007, 6]]}, "references-count": 9, "journal-issue": {"published-print": {"date-parts": [[2007, 6]]}, "issue": "6"}, "alternative-id": ["S1470204507701547"], "URL": "http://dx.doi.org/10.1016/s1470-2045(07)70154-7", "ISSN": ["1470-2045"], "issn-type": [{"value": "1470-2045", "type": "print"}], "subject": ["Oncology"]}, {"indexed": {"date-parts": [[2018, 9, 5]], "date-time": "2018-09-05T10:40:28Z", "timestamp": 1536144028611}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2017, 1, 1]], "date-time": "2017-01-01T00:00:00Z", "timestamp": 1483228800000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2018, 1, 1]], "date-time": "2018-01-01T00:00:00Z", "timestamp": 1514764800000}, "delay-in-days": 365, "content-version": "vor"}], "content-domain": {"domain": ["jto.org", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Journal of Thoracic Oncology"], "published-print": {"date-parts": [[2017, 1]]}, "DOI": "10.1016/j.jtho.2016.11.043", "type": "journal-article", "created": {"date-parts": [[2017, 1, 4]], "date-time": "2017-01-04T03:16:07Z", "timestamp": 1483499767000}, "page": "S48-S49", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["ED10.03 New Developments in Radiotherapy of Stage III NSCLC"], "prefix": "10.1016", "volume": "12", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Journal of Thoracic Oncology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1556086416312849?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1556086416312849?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 5]], "date-time": "2018-09-05T10:24:48Z", "timestamp": 1536143088000}, "score": 26.512724, "issued": {"date-parts": [[2017, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2017, 1]]}, "issue": "1"}, "alternative-id": ["S1556086416312849"], "URL": "http://dx.doi.org/10.1016/j.jtho.2016.11.043", "ISSN": ["1556-0864"], "issn-type": [{"value": "1556-0864", "type": "print"}], "subject": ["Oncology", "Pulmonary and Respiratory Medicine"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "ED10.03 New Developments in Radiotherapy of Stage III NSCLC", "name": "articletitle", "label": "Article Title"}, {"value": "Journal of Thoracic Oncology", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.jtho.2016.11.043", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "simple-article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2016 Published by Elsevier Inc.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2018, 8, 30]], "date-time": "2018-08-30T19:10:38Z", "timestamp": 1535656238514}, "reference-count": 43, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2017, 8, 1]], "date-time": "2017-08-01T00:00:00Z", "timestamp": 1501545600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "thebreastonline.com", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["The Breast"], "published-print": {"date-parts": [[2017, 8]]}, "DOI": "10.1016/j.breast.2017.06.037", "type": "journal-article", "created": {"date-parts": [[2017, 7, 1]], "date-time": "2017-07-01T00:17:42Z", "timestamp": 1498868262000}, "page": "S95-S98", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Post-mastectomy radiation therapy after breast reconstruction: Indications, timing and results"], "prefix": "10.1016", "volume": "34", "author": [{"given": "Jacek", "family": "Jassem", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["The Breast"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S096097761730509X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S096097761730509X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 8, 30]], "date-time": "2018-08-30T18:32:23Z", "timestamp": 1535653943000}, "score": 26.512724, "issued": {"date-parts": [[2017, 8]]}, "references-count": 43, "alternative-id": ["S096097761730509X"], "URL": "http://dx.doi.org/10.1016/j.breast.2017.06.037", "ISSN": ["0960-9776"], "issn-type": [{"value": "0960-9776", "type": "print"}], "subject": ["Surgery", "General Medicine"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Post-mastectomy radiation therapy after breast reconstruction: Indications, timing and results", "name": "articletitle", "label": "Article Title"}, {"value": "The Breast", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.breast.2017.06.037", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2017 Elsevier Ltd. All rights reserved.", "name": "copyright", "label": "Copyright"}]}], "items-per-page": 25, "query": {"start-index": 0, "search-terms": null}}, "custom_name_alias": "JASSEM JACEK"}